PharmCAT.NET

Biostatistics, pharmacokinetics and clinical trials.

  • Home page
  • Blog
  • Contacts
  • Agreement & Confidentiality

IBM SPSS Extension: R Project PowerTOST library

Posted on December 31, 2018December 31, 2018 by frozencat

IBM SPSS Extension PowerTOST R Project library. Syntax command: POWERTOST.

Version: 1.0.0

Functions:

  • power.TOST
  • sampleN.TOST
  • CVfromCI

Дизайны:

  • parallel
  • 2×2
  • 2x2x4

Скачать/Download

GitHUB: https://github.com/PharmCat/SPSSPowerTOST

Categories: Blog, SPSS

Post navigation

Next Post:

Recent Posts

  • IBM SPSS + R Project: Confidence intervals for proportions, independent groups
  • IBM SPSS Extension: R Project PowerTOST library

Галерея

20180131 155935
20180814 210717
20170730 184036
20170804 134902
20180816 140357
20170731 215853
  • FDA Approves Expanded Use of Vonvendi for von Willebrand Disease, Including for Certain Uses for Children
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-06 By FDA
  • Pain and Arthritis Products Containing Hidden Ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • FTX PLUS may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Patient-Focused Drug Development: Workshop #2 to Discuss Methodologic and Other Challenges Related to Patient Experience Data - 09/18/2025
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • REUMA KING may be harmful due to hidden drug ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Condition-Specific Meeting Reports and Other Information Related to Patients' Experience
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Upcoming EL-PFDD Meetings
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • GDUFA Paid Facilities List
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Generic Drugs Program Monthly and Quarterly Activities Report
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Completed BsUFA III Deliverables
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Human medicines European public assessment report (EPAR): Sephience, sepiapterin, Date of authorisation: 19/06/2025, Revision: 1, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-05
  • Human medicines European public assessment report (EPAR): Sunosi, solriamfetol, Date of authorisation: 16/01/2020, Revision: 10, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-05
  • FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • FDA Launches Green List to Protect Americans from Illegal Imported GLP-1 Drug Ingredients
    Source: FDA - What's New: Drugs RSS Feed Published on 2025-09-05 By FDA
  • Human medicines European public assessment report (EPAR): Wakix, pitolisant, Date of authorisation: 31/03/2016, Revision: 18, Status: Authorised
    Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2025-09-05
Older posts
Theme: Scaffold by Danny Cooper.